Synthesis and Immunological Evaluation of a Single Molecular Construct MUC1 Vaccine Containing l-Rhamnose Repeating Units
出版年份 2020 全文链接
标题
Synthesis and Immunological Evaluation of a Single Molecular Construct MUC1 Vaccine Containing l-Rhamnose Repeating Units
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 14, Pages 3137
出版商
MDPI AG
发表日期
2020-07-10
DOI
10.3390/molecules25143137
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses
- (2019) Md Hossain et al. Cancers
- Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes
- (2019) Neha Nandedkar-Kulkarni et al. BIOCONJUGATE CHEMISTRY
- Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies
- (2018) Md Kamal Hossain et al. ACS Chemical Biology
- Glycopeptide-functionalized gold nanoparticles for antibody induction against the tumor associated mucin-1 glycoprotein
- (2016) Hui Cai et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
- (2016) Vani Lakshminarayanan et al. PLoS One
- Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses
- (2015) Partha Karmakar et al. BIOCONJUGATE CHEMISTRY
- MUC1 (CD227): a multi-tasked molecule
- (2015) Vasso Apostolopoulos et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide
- (2015) Pamela Thompson et al. CHEMICAL COMMUNICATIONS
- Enhanced immunogenicity of multivalent MUC1 glycopeptide antitumour vaccines based on hyperbranched polymers
- (2015) M. Glaffig et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit
- (2015) Wuguang Lu et al. Oncotarget
- Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets
- (2015) Enric Gutiérrez-Martínez Frontiers in Immunology
- Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-Carbohydrate Antibodies to Tumor Cells
- (2014) Rachael T. C. Sheridan et al. CHEMBIOCHEM
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- Synthesis and Immunological Evaluation of a MUC1 Glycopeptide Incorporated into l-Rhamnose Displaying Liposomes
- (2013) Sourav Sarkar et al. BIOCONJUGATE CHEMISTRY
- Antitumor effect of adenoviral vector prime protein boost immunity targeting the MUC1 VNTRs
- (2013) YUQIAN WANG et al. ONCOLOGY REPORTS
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
- (2010) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis of a Single-Moleculel-Rhamnose-Containing Three-Component Vaccine and Evaluation of Antigenicity in the Presence of Anti-l-Rhamnose Antibodies
- (2010) Sourav Sarkar et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Profiling Human Serum Antibodies with a Carbohydrate Antigen Microarray
- (2009) Oyindasola Oyelaran et al. JOURNAL OF PROTEOME RESEARCH
- Generation of Bone Marrow Derived Murine Dendritic Cells for Use in 2-photon Imaging
- (2008) Melanie P. Matheu et al. Jove-Journal of Visualized Experiments
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started